KR840001829A - Method for preparing tablets containing new fenprodil - Google Patents

Method for preparing tablets containing new fenprodil Download PDF

Info

Publication number
KR840001829A
KR840001829A KR1019820004798A KR820004798A KR840001829A KR 840001829 A KR840001829 A KR 840001829A KR 1019820004798 A KR1019820004798 A KR 1019820004798A KR 820004798 A KR820004798 A KR 820004798A KR 840001829 A KR840001829 A KR 840001829A
Authority
KR
South Korea
Prior art keywords
tableting
composition
fenprodil
tablets containing
containing new
Prior art date
Application number
KR1019820004798A
Other languages
Korean (ko)
Inventor
야즈야 사까이 (외 3)
Original Assignee
스즈끼 시개끼
가부시기 가이샤 코스모스·엔타아프라이즈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스즈끼 시개끼, 가부시기 가이샤 코스모스·엔타아프라이즈 filed Critical 스즈끼 시개끼
Publication of KR840001829A publication Critical patent/KR840001829A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

내용 없음No content

Description

새로운 이펜프로딜을 함유하는 정제의 제조방법Method for preparing tablets containing new fenprodil

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (3)

유당과 히드록시 프로필 셀룰로오스로 제조된 과립과 분말상태에 있는 그대로의 주석산이펜프로딜과 분말상태에 있는 그대로의 부형제와를, 붕괴제를 첨가하지 않고 혼합하여 타정용 조성물을 조제한 다음 이 조성물을 타정하는 것을 특징으로 하는 신규의 주석산 이펜 프로딜을 함유하는 정제의 제조방법.Granules made of lactose and hydroxypropyl cellulose, and ipfenprodil as it is in powder form and excipients as it is in powder form are mixed without adding a disintegrant to prepare a tableting composition. A process for producing a novel tablet containing stannic acid ifenprodil, characterized in that it is compressed. 특허청구의 범위 제1항에 기재한 전기의 부형제가 타정용 조성물에 대하여 5∼20중량%비율의 결정 셀룰로오스임을 특징으로 하는 정제의 제조방법.The manufacturing method of the tablet characterized by the above-mentioned excipient of Claim 1 which is 5-20 weight% of crystalline cellulose with respect to a composition for tableting. 특허청구의 범위 제1항에 기재한 전기의 조성물을 타정할 때 활탁제로서 타정용 조성물에 대하여, 0.5∼2%중량비율의 스테아린산 마그네슘을 사용하는 것을 특징으로 하는 정제의 제조방법.The tablet manufacturing method characterized by using the magnesium stearate of 0.5 to 2% weight ratio with respect to a composition for tableting as a lubricating agent when tableting the former composition of Claim 1. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019820004798A 1981-10-30 1981-10-26 Method for preparing tablets containing new fenprodil KR840001829A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56172973A JPS5874604A (en) 1981-10-30 1981-10-30 Production of novel type of tablet containing ifenprodyl
JP81-172973 1981-10-30

Publications (1)

Publication Number Publication Date
KR840001829A true KR840001829A (en) 1984-06-07

Family

ID=15951788

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019820004798A KR840001829A (en) 1981-10-30 1981-10-26 Method for preparing tablets containing new fenprodil

Country Status (5)

Country Link
JP (1) JPS5874604A (en)
KR (1) KR840001829A (en)
BE (1) BE894855A (en)
FR (1) FR2515515B1 (en)
PH (1) PH19876A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010280601A (en) * 2009-06-04 2010-12-16 Suntory Holdings Ltd Tablet highly containing xylo-oligosaccharide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5733M (en) * 1966-09-27 1968-01-22

Also Published As

Publication number Publication date
BE894855A (en) 1983-02-14
JPS5874604A (en) 1983-05-06
FR2515515A1 (en) 1983-05-06
PH19876A (en) 1986-08-13
JPH0136806B2 (en) 1989-08-02
FR2515515B1 (en) 1987-01-30

Similar Documents

Publication Publication Date Title
KR840005661A (en) Process for preparing a persistent matrix tablet composition
KR880010757A (en) Pharmaceutical tablets, pharmaceutical granules and manufacturing method thereof
KR890001526A (en) Oral sustained release acetaminophen formulations and preparation method thereof
IL42232A (en) Dry medicines for oral administration
ES430431A1 (en) Direct compression tabletting composition and pharmaceutical tablets produced therefrom
KR890004686A (en) Sustained release Etodolac
ES392066A1 (en) Tablets containing l-dopa
AR246012A1 (en) Direct compression cholestyramine tablet and solvent-free coating therefor
MY103076A (en) Ibuprofen sustained release matrix and process
DK0525389T3 (en) Process for the preparation of mechanically stable, lightly decomposing tablets of active ingredient molds
UA41346C2 (en) Pharmaceutical composition containing fluoxetin or its salt, tablet based on composition thereof, method for manufacturing dispersed tablets
US4203997A (en) Directly-pressable ascorbic acid-containing granulates
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
GB1109186A (en) Novel vitamin compositions and a process for the manufacture thereof
DE3063858D1 (en) Process for the production of a solid form containing a pharmaceutical active agent or a diagnostic
RU2002123182A (en) CONTAINING IBUPROFEN COMPOSITION
KR910011241A (en) Spray drying to prepare pharmaceutical powder compositions that can be compressed directly into tablets
GB1484832A (en) Tablets
US3493659A (en) Compositions and process for the production thereof
JPS5420126A (en) Pharmaceutical composition
KR840001829A (en) Method for preparing tablets containing new fenprodil
GB1464200A (en) Pharmaceutical composition
HU912374D0 (en) Process for the production of tablets and granulateswith mesna content
JPH0769889A (en) Preparation of nicorandil tablet
DE3274185D1 (en) Medicinal preparations for glycoside-hydrolase inhibitors